KOSME (Korea SMEs & Startups Agency)

Description

KOSME (Korea SMEs and Startups Agency) KOSME is a South Korean government agency supporting the growth and global expansion of Korean SMEs and startups. Through a network of 21 Global Business Centers and 5 K-Startup Centers, KOSME provides financial support, consulting, training, and networking to help innovative companies enter and scale in international markets. The K-Startup Center Paris, established by KOSME (Korea SMEs and Startups Agency), serves as a key global hub for Korean startups seeking to expand into France and Europe. Located at Station F in Paris, the center offers office space, mentorship, networking opportunities, and tailored programs to support startups entering the European market. By providing essential resources and connections, the center strengthens South Korea’s position as a global leader in innovation and entrepreneurship. Meet Our Startups DRIMAES is a smart mobility company specializing in integrated technologies for Software-Defined Vehicles (SDV) and In-Vehicle Infotainment (IVI). Through its on-device AI–based control platform, DRIMAES provides personalized in-cabin experiences. Its web-based architecture enables seamless expansion of in-vehicle services. With expertise in AUTOSAR-based ECU development and virtual validation, DRIMAES collaborates with global OEMs. DRIMAES leads the evolution of software-defined mobility. TiP (Travel in Your Pocket) is an all-in-one AI travel concierge that merges intelligent trip planning, real-time assistance, and secure blockchain payments — all within a single app. Through its global partnerships with leading luxury hotels and travel brands, TiP users gain access to exclusive perks, upgrades, and VIP benefits usually reserved for top-tier travelers. Experience the future of luxury travel — smarter, faster, and more rewarding. TALOS Corp. specializes in developing AI-based algorithms to provide a preventative solution for early detection by analyzing the risk of developing cardiovascular diseases. Its flagship product, ANRISK®, predicts the likelihood of brain aneurysm formation using routine health-check data, enabling early and cost-effective screening before imaging. Clinically validated and currently deployed across hospitals and corporations in Korea, TALOS is expanding globally to advance predictive and preventive medicine.

Our Medias